TransMedics Group, Inc. Stock-Based Compensation
TransMedics Group, Inc. (TMDX) reported Stock-Based Compensation of $18.56 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-04
- TransMedics Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $8.61M, a 8.17% decline year-over-year.
- TransMedics Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $9.95M, a 11.10% increase year-over-year.
- TransMedics Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $9.39M, a 12.74% decline year-over-year.
- TransMedics Group, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $9.14M, a 15.01% increase year-over-year.
- TransMedics Group, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $36.86M, a 10.95% increase from fiscal 2024.
- TransMedics Group, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $33.22M, a 67.87% increase from fiscal 2023.
- TransMedics Group, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $19.79M, a 91.75% increase from fiscal 2022.
- TransMedics Group, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $10.32M, a 50.06% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $8.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $18.56M 10-Q · filed 2026-08-04 | $27.95M derived: sum of 3 quarters · filed 2026-08-04 | $37.09M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $9.95M 10-Q · filed 2026-05-05 | $19.35M derived: sum of 2 quarters · filed 2026-05-05 | $28.48M derived: sum of 3 quarters · filed 2026-05-05 | $37.85M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $9.39M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $18.53M derived: sum of 2 quarters · filed 2026-02-24 | $27.90M derived: sum of 3 quarters · filed 2026-08-04 | $36.86M 10-K · filed 2026-02-24 |
| 2025-09-30 | $9.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $18.51M derived: sum of 2 quarters · filed 2026-08-04 | $27.47M 10-Q · filed 2025-10-29 | $38.23M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $9.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $18.33M 10-Q · filed 2026-08-04 | $29.10M derived: sum of 3 quarters · filed 2026-08-04 | $37.04M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $8.96M 10-Q · filed 2026-05-05 | $19.73M derived: sum of 2 quarters · filed 2026-05-05 | $27.67M derived: sum of 3 quarters · filed 2026-05-05 | $35.31M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $10.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $18.71M derived: sum of 2 quarters · filed 2026-02-24 | $26.35M derived: sum of 3 quarters · filed 2026-02-24 | $33.22M 10-K · filed 2026-02-24 |
| 2024-09-30 | $7.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $15.59M derived: sum of 2 quarters · filed 2025-10-29 | $22.46M 10-Q · filed 2025-10-29 | $28.18M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $7.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $14.51M 10-Q · filed 2025-07-30 | $20.24M derived: sum of 3 quarters · filed 2026-02-24 | $25.43M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $6.87M 10-Q · filed 2025-05-08 | $12.59M derived: sum of 2 quarters · filed 2026-02-24 | $17.78M derived: sum of 3 quarters · filed 2026-02-24 | $22.74M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $5.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $10.91M derived: sum of 2 quarters · filed 2026-02-24 | $15.87M derived: sum of 3 quarters · filed 2026-02-24 | $19.79M 10-K · filed 2026-02-24 |
| 2023-09-30 | $5.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $10.15M derived: sum of 2 quarters · filed 2024-10-29 | $14.07M 10-Q · filed 2024-10-29 | $17.06M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $4.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $8.88M 10-Q · filed 2024-08-01 | $11.87M derived: sum of 3 quarters · filed 2025-02-27 | $14.57M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $3.92M 10-Q · filed 2024-05-02 | $6.91M derived: sum of 2 quarters · filed 2025-02-27 | $9.62M derived: sum of 3 quarters · filed 2025-02-27 | $11.93M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.70M derived: sum of 2 quarters · filed 2025-02-27 | $8.01M derived: sum of 3 quarters · filed 2025-02-27 | $10.32M 10-K · filed 2025-02-27 |
| 2022-09-30 | $2.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $5.02M derived: sum of 2 quarters · filed 2023-11-08 | $7.33M 10-Q · filed 2023-11-08 | $9.31M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $4.63M 10-Q · filed 2023-08-04 | $6.61M derived: sum of 3 quarters · filed 2024-02-27 | $8.58M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $2.31M 10-Q · filed 2023-05-04 | $4.29M derived: sum of 2 quarters · filed 2024-02-27 | $6.27M derived: sum of 3 quarters · filed 2024-02-27 | $8.08M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $3.96M derived: sum of 2 quarters · filed 2024-02-27 | $5.77M derived: sum of 3 quarters · filed 2024-02-27 | $6.88M 10-K · filed 2024-02-27 |
| 2021-09-30 | $1.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $3.78M derived: sum of 2 quarters · filed 2022-11-04 | $4.89M 10-Q · filed 2022-11-04 | $5.59M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $2.92M 10-Q · filed 2022-08-03 | $3.62M derived: sum of 3 quarters · filed 2023-02-27 | $4.32M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $1.11M 10-Q · filed 2022-05-05 | $1.81M derived: sum of 2 quarters · filed 2023-02-27 | $2.51M derived: sum of 3 quarters · filed 2023-02-27 | $3.14M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $698.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $1.40M derived: sum of 2 quarters · filed 2023-02-27 | $2.03M derived: sum of 3 quarters · filed 2023-02-27 | $2.41M 10-K · filed 2023-02-27 |
| 2020-09-30 | $700.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.33M derived: sum of 2 quarters · filed 2021-11-09 | $1.72M 10-Q · filed 2021-11-09 | $2.00M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $631.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $1.02M 10-Q · filed 2021-08-06 | $1.30M derived: sum of 3 quarters · filed 2021-05-07 | $1.59M derived: sum of 4 quarters · filed 2021-05-07 |
| 2020-03-31 | $385.00K 10-Q · filed 2021-05-07 | $667.00K derived: sum of 2 quarters · filed 2021-05-07 | $962.00K derived: sum of 3 quarters · filed 2021-05-07 | $1.18M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $577.00K derived: sum of 2 quarters · filed 2021-03-11 | $797.00K derived: sum of 3 quarters · filed 2021-03-11 | $854.00K 10-K · filed 2021-03-11 |
| 2019-09-28 | $295.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $515.00K derived: sum of 2 quarters · filed 2020-08-07 | $572.00K 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $220.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $277.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $57.00K 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $144.00K 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $92.00K 10-Q · filed 2019-11-08 | |||
| 2018-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $61.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $27.00K 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |